Search Results - I‐Ming Wang
- Showing 1 - 1 results of 1
-
1
PK/PD model‐informed dose selection for oncology phase I expansion: Case study based on PF‐06939999, a PRMT5 inhibitor by Cen Guo, Kai H. Liao, Meng Li, I‐Ming Wang, Naveed Shaik, Donghua Yin
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book